BMSSC
ABBV icon

B. Metzler seel. Sohn & Co’s AbbVie ABBV Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218M Sell
867,621
-82,764
-9% -$17.8M 1.89% 14
2026
Q1 		$207M Buy
950,385
+116,708
+14% +$25.9M 1.92% 14
2025
Q4 		$191M Buy
833,677
+335,055
+67% +$76.3M 1.66% 16
2025
Q3 		$115M Buy
498,622
+27,906
+6% +$5.68M 1.02% 23
2025
Q2 		$87.4M Sell
470,716
-14,081
-3% -$2.62M 0.84% 24
2025
Q1 		$102M Buy
484,797
+49,266
+11% +$9.58M 1.05% 22
2024
Q4 		$77.3M Sell
435,531
-17,276
-4% -$3.18M 0.8% 25
2024
Q3 		$89.4M Sell
452,807
-37,812
-8% -$7.06M 0.89% 23
2024
Q2 		$84.1M Buy
490,619
+33,913
+7% +$5.62M 0.81% 25
2024
Q1 		$83.2M Buy
456,706
+74,241
+19% +$12.8M 0.92% 23
2023
Q4 		$59.3M Buy
382,465
+28,583
+8% +$4.17M 0.76% 24
2023
Q3 		$52.7M Buy
353,882
+7,470
+2% +$1.1M 0.8% 22
2023
Q2 		$46.7M Buy
346,412
+22,543
+7% +$3.31M 0.63% 26
2023
Q1 		$51.6M Sell
323,869
-63,986
-16% -$9.78M 0.8% 18
2022
Q4 		$62.7M Buy
387,855
+35,604
+10% +$5.46M 1.07% 17
2022
Q3 		$47.3M Sell
352,251
-8,518
-2% -$1.22M 0.86% 19
2022
Q2 		$55.3M Buy
360,769
+8,837
+3% +$1.35M 0.91% 21
2022
Q1 		$57.1M Buy
351,932
+78,801
+29% +$11.4M 0.76% 24
2021
Q4 		$37.1M Buy
273,131
+50,618
+23% +$5.98M 0.48% 41
2021
Q3 		$24M Buy
222,513
+26,329
+13% +$3.01M 0.35% 49
2021
Q2 		$22.1M Sell
196,184
-2,441
-1% -$275K 0.33% 55
2021
Q1 		$21.5M Sell
198,625
-6,650
-3% -$711K 0.35% 48
2020
Q4 		$23.6M Buy
+205,275
New +$19.7M 0.44% 37

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

B. Metzler seel. Sohn & Co's ABBV Position: Q2 2026 in Review

B. Metzler seel. Sohn & Co reduced its AbbVie (ABBV) stake by 8.7% in Q2 2026, selling an estimated $17.8M and leaving 867,621 shares worth $218M. The position accounts for 1.89% of the portfolio, ranked #14.

B. Metzler seel. Sohn & Co first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • B. Metzler seel. Sohn & Co held 867,621 shares of AbbVie worth $218M as of Q2 2026.
  • B. Metzler seel. Sohn & Co sold 82,764 AbbVie shares in Q2 2026, an estimated $17.8M.
  • AbbVie made up 1.89% of B. Metzler seel. Sohn & Co's portfolio in Q2 2026, its #14 holding.
  • B. Metzler seel. Sohn & Co first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q2 2026, filed 11 Aug 2026.